Federal Express Corporation (FedEx), one of the world’s largest express transportation companies, has expanded its state-of-the-art life sciences center in Gimpo, Gyeonggi-do, Korea. This strategic enhancement, along with FedEx Life Science Centers in Singapore and Japan, addresses the growing demand for a robust logistics network with advanced capabilities to support the rapidly growing healthcare sector across the Asia Pacific region.
The advanced FedEx Korea Life Science Center spans 2,288 square meters – nearly three times the size of the previous facility. The new process includes five temperature-controlled zones for temperatures ranging from -150°C to +25°C, which are monitored 24/7 to ensure ongoing compliance with pharmaceutical cold chain requirements. facility too Certified by the Korean Good Sourcing Practices (KGSP) according With market-specific quality and regulatory requirements of the healthcare industry. Combined with temperature-controlled inventory management capabilities, the Korea Life Sciences Center is equipped to support domestic and international transportation needs.
By expanding its capacity, FedEx is enhancing its life sciences logistics expertise, ensuring the seamless and reliable transportation of critical healthcare shipments, including investigational medicinal products (IMP), biological samples, and biopharmaceutical product lines, while enabling pharmaceutical and clinical trial customers to Prioritize patient care.
The Asia Pacific pharmaceutical market is expected to reach US$290 billion by 2028. In addition, the region accounts for approximately 50% of global clinical trialshighlighting its growing role in global pharmaceutical research and development. Customers in the healthcare and pharmaceutical sectors require precise, temperature-controlled services to maintain product effectiveness. With decades of experience, FedEx It provides expertise in specialty healthcare and clinical trial solutions, thanks to its rapid international network, dedicated Time Critical Special Services (SPS) and a global network of Life Sciences Centers with locations in Korea, Singapore and Tokyo. (Japan), Mumbai (India), Memphis (United States), and Veldhoven (Netherlands). The company’s comprehensive healthcare infrastructure also includes more than 130 cold chain facilities across the globe, ensuring constant temperature integrity. For shipments traveling through our local and international networks.
“The healthcare sector in the Asia Pacific region is evolving at an unprecedented pace, driven by demographic shifts, infrastructure investments, and rapid technological advances,” said Koel Britt, president, Asia Pacific, FedEx. “At FedEx, we leverage our decades of healthcare experience, extensive global network and diverse solutions to drive this growth. Through strategic investments in cutting-edge facilities and intelligent AI-driven logistics, we are reshaping healthcare supply chains and enabling… The future of life sciences research and commercial innovation across the region.
FedEx Clinical Care, part of the company’s suite of customized healthcare transportation solutions, provides comprehensive delivery capabilities for time- and temperature-sensitive healthcare shipments. This service ensures rapid delivery within 24 to 48 hours, leveraging specialized features including temperature-controlled packaging, priority handling and clearance, and 24/7 monitoring and intervention using real-time sensor-based tracking.
